- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Lixisenatide – July 2014
Lixisenatide,10 micrograms/0.2 ml injection, 14 unit doses (&) 20 micrograms/0.2 ml injection, 14 unit doses, Lyxumia® Treatment Initiation Pack, 20 micrograms/0.2 ml injection, 2 x 14 unit doses, Lyxumia®, Sanofi-Aventis Australia Pty Ltd
Last updated
8 November 2023